Aditxt, Inc.

NASDAQ: ADTX · Healthcare · Biotechnology

PublicHQ Mountain View, VACIK 0001726711Reports USD

#1129 of 1,394 Healthcare companies by revenuebottom-decile growth

EA Score

18D

FH 15DQ 23GM 11SS 24

v0.1 · 65/100 weight · provisional

↑ workforce scale, balance-sheet leverage · ↓ operating margin, net margin

Methodology →

Revenue TTM

$14.3k

Rev growth YoY (TTM)

-74.1%

Net income (FY)

-$43.1M

Employees

Market cap

$174

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$3.2k$3.2k2025

Net income-$43.1M-$43.1M2025

Operating income-$19.6M-$19.6M2025

Total assets$16.5M$16.5M2025

Liabilities$12.6M$12.6M2025

Equity$5.6M$5.6M2025

Revenue trend

FY2021 – FY2025 · USD

$105.0k

FY21

$933.7k

FY22

$645.2k

FY23

$134.0k

FY24

$3.2k

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Aditxt, Inc. booked $3.2k in FY2025 revenue, contracting 98% year over year — among the slowest-growing Healthcare companies we track, at a -1349028.2% net margin.

Peers · Healthcare

Clever Leaves Holdings Inc.——MedAvail Holdings, Inc.——Poniard Pharmaceuticals, Inc.——9 Meters Biopharma, Inc.——

Key facts

CEOAmro A. Albanna

SectorHealthcare

IndustryBiotechnology

HeadquartersMountain View, VA

ExchangeNASDAQ: ADTX

Employees26

IPO date2020-06-30

Latest filings

8-K2026-06-24 8-K2026-06-23 8-K2026-06-10 8-K2026-06-09 8-K2026-06-05 8-K2026-06-01 8-K2026-05-29 10-Q2026-05-20

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.